Select Medical - SEM Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $34.25
  • Forecasted Upside: -8.64%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$37.49
▲ +0.49 (1.32%)

This chart shows the closing price for SEM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Select Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SEM

Analyst Price Target is $34.25
▼ -8.64% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Select Medical in the last 3 months. The average price target is $34.25, with a high forecast of $40.00 and a low forecast of $26.00. The average price target represents a -8.64% upside from the last price of $37.49.

This chart shows the closing price for SEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 investment analysts is to moderate buy stock in Select Medical. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/16/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/15/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$36.00 ➝ $40.00Low
5/3/2024BenchmarkReiterated RatingBuy ➝ Buy$39.00 ➝ $39.00Low
4/12/2024BenchmarkReiterated RatingBuy ➝ Buy$39.00Low
11/30/2023UBS GroupInitiated CoverageNeutral$26.00Low
11/8/2023BenchmarkReiterated RatingBuy ➝ Buy$39.00Low
8/7/2023Credit Suisse GroupBoost TargetNeutral ➝ Neutral$29.00 ➝ $32.00Low
7/20/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$38.00Low
5/8/2023Royal Bank of CanadaBoost Target$32.00 ➝ $38.00Low
5/8/2023Deutsche Bank AktiengesellschaftBoost Target$35.00 ➝ $37.00Low
2/27/2023Credit Suisse GroupBoost TargetNeutral$24.00 ➝ $29.00Low
2/27/2023BenchmarkReiterated RatingBuy$39.00Low
11/24/2022Credit Suisse GroupSet Target$24.00Low
11/7/2022Royal Bank of CanadaLower TargetOutperform$36.00 ➝ $32.00Low
11/7/2022Deutsche Bank AktiengesellschaftLower Target$44.00 ➝ $35.00Low
8/15/2022BenchmarkLower Target$39.00Low
5/17/2022Credit Suisse GroupLower TargetNeutral$27.00Low
3/16/2022Credit Suisse GroupLower TargetNeutral$37.00 ➝ $28.00Medium
3/7/2022Royal Bank of CanadaLower TargetOutperform$47.00 ➝ $42.00Medium
1/19/2022Deutsche Bank AktiengesellschaftLower Target$48.00 ➝ $44.00High
1/18/2022Bank of AmericaLower TargetBuy$40.00 ➝ $35.00High
1/18/2022Royal Bank of CanadaLower TargetOutperform$50.00 ➝ $47.00High
8/10/2021Credit Suisse GroupBoost TargetNeutral$37.00 ➝ $39.00Low
6/23/2021BenchmarkBoost TargetBuy$44.00 ➝ $50.00Medium
5/17/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$42.00 ➝ $46.00Medium
5/13/2021BenchmarkBoost TargetBuy$40.00 ➝ $44.00High
5/10/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$42.00 ➝ $46.00Medium
3/1/2021Credit Suisse GroupBoost TargetNeutral$32.00 ➝ $34.00Low
2/26/2021Bank of AmericaUpgradeUnderperform ➝ Buy$30.00 ➝ $36.00High
2/17/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$27.00 ➝ $34.00Low
1/5/2021Credit Suisse GroupBoost TargetNeutral$22.00 ➝ $27.00N/A
11/2/2020Credit Suisse GroupBoost TargetNeutral$19.00 ➝ $22.00High
8/4/2020Deutsche Bank AktiengesellschaftBoost TargetPositive ➝ Buy$24.00 ➝ $26.00Low
8/3/2020Credit Suisse GroupBoost TargetNeutral$18.00 ➝ $19.00Low
6/16/2020Bank of AmericaDowngradeNeutral ➝ Underperform$18.00 ➝ $15.00High
5/4/2020Credit Suisse GroupLower TargetNeutral$23.00 ➝ $18.00Low
5/4/2020Wells Fargo & CompanyLower TargetOverweight$31.00 ➝ $24.00High
4/24/2020Deutsche Bank AktiengesellschaftLower TargetBuy$33.00 ➝ $24.00High
4/20/2020Royal Bank of CanadaReiterated RatingBuy$26.00Low
4/3/2020Credit Suisse GroupLower TargetNeutral$29.00 ➝ $23.00High
3/24/2020BenchmarkLower TargetBuy$33.00 ➝ $25.00High
2/24/2020Royal Bank of CanadaReiterated RatingOutperform ➝ Positive$32.00High
2/24/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$22.00 ➝ $33.00High
1/28/2020Royal Bank of CanadaReiterated RatingOutperform$27.00High
11/1/2019Credit Suisse GroupSet TargetHold$18.00High
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$22.00Low
(Data available from 7/15/2019 forward)

News Sentiment Rating

0.63 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 10 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 12 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/16/2024
  • 14 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/17/2024
  • 8 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/16/2024
  • 10 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/16/2024
  • 8 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/15/2024
  • 6 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 6 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Select Medical logo
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Read More

Today's Range

Now: $37.49
Low: $37.09
High: $37.81

50 Day Range

MA: $34.29
Low: $32.11
High: $37.51

52 Week Range

Now: $37.49
Low: $21.28
High: $37.81

Volume

449,700 shs

Average Volume

589,411 shs

Market Capitalization

$4.87 billion

P/E Ratio

17.85

Dividend Yield

1.33%

Beta

1.43

Frequently Asked Questions

What sell-side analysts currently cover shares of Select Medical?

The following Wall Street sell-side analysts have issued reports on Select Medical in the last twelve months: Benchmark Co., Credit Suisse Group AG, Royal Bank of Canada, StockNews.com, TheStreet, and UBS Group AG.
View the latest analyst ratings for SEM.

What is the current price target for Select Medical?

4 Wall Street analysts have set twelve-month price targets for Select Medical in the last year. Their average twelve-month price target is $34.25, suggesting a possible downside of 8.6%. Royal Bank of Canada has the highest price target set, predicting SEM will reach $40.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $26.00 for Select Medical in the next year.
View the latest price targets for SEM.

What is the current consensus analyst rating for Select Medical?

Select Medical currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SEM.

What other companies compete with Select Medical?

How do I contact Select Medical's investor relations team?

Select Medical's physical mailing address is 4714 GETTYSBURG ROAD P.O. BOX 2034, MECHANICSBURG PA, 17055. The health services provider's listed phone number is (717) 972-1100 and its investor relations email address is [email protected]. The official website for Select Medical is www.selectmedicalcorp.com. Learn More about contacing Select Medical investor relations.